<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">752</article-id><article-id pub-id-type="doi">10.54101/ACEN.2022.1.6</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Technologies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Технологии</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Bilateral stimulation of the subthalamic nucleus under local and general anaesthesia</article-title><trans-title-group xml:lang="ru"><trans-title>Двусторонняя стимуляция субталамического ядра в условиях общей и местной анестезии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1821-6323</contrib-id><name-alternatives><name xml:lang="en"><surname>Asriyants</surname><given-names>Svetlana V.</given-names></name><name xml:lang="ru"><surname>Асриянц</surname><given-names>Светлана Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>neurosurgeon</p></bio><bio xml:lang="ru"><p>врач-нейрохирург</p></bio><email>sasriyanc@nsi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2120-0146</contrib-id><name-alternatives><name xml:lang="en"><surname>Tomskiy</surname><given-names>Alexey A.</given-names></name><name xml:lang="ru"><surname>Томский</surname><given-names>Алексей Алексеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Head, Group of the functional neurosurgery</p></bio><bio xml:lang="ru"><p>к.м.н., рук. группы функциональной нейрохирургии</p></bio><email>atomski@nsi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6412-8148</contrib-id><name-alternatives><name xml:lang="en"><surname>Gamaleya</surname><given-names>Anna A.</given-names></name><name xml:lang="ru"><surname>Гамалея</surname><given-names>Анна Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>neurologist</p></bio><bio xml:lang="ru"><p>невролог</p></bio><email>agamaleya@nsi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5776-3442</contrib-id><name-alternatives><name xml:lang="en"><surname>Poddubskaya</surname><given-names>Anna A.</given-names></name><name xml:lang="ru"><surname>Поддубская</surname><given-names>Анна Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>neurologist</p></bio><bio xml:lang="ru"><p>невролог</p></bio><email>apoddubskaya@nsi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3885-2578</contrib-id><name-alternatives><name xml:lang="en"><surname>Sedov</surname><given-names>Alexey S.</given-names></name><name xml:lang="ru"><surname>Седов</surname><given-names>Алексей Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.), Head, Human cell neurophysiology laboratory</p></bio><bio xml:lang="ru"><p>к.б.н., зав. лаб. клеточной нейрофизиологии человека</p></bio><email>alexeys.sedov@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4480-0275</contrib-id><name-alternatives><name xml:lang="en"><surname>Pronin</surname><given-names>Igor N.</given-names></name><name xml:lang="ru"><surname>Пронин</surname><given-names>Игорь Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Professor, Full member of RAS, Head, Radiology department, Deputy director for scientific work</p></bio><bio xml:lang="ru"><p>д.м.н., проф., академик РАН, зав. отд. рентгеновских и радиоизотопных методов, зам. директора по научной работе</p></bio><email>pronin@nsi.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Burdenko Neurosurgical Center</institution></aff><aff><institution xml:lang="ru">ФГАУ «Национальный медицинский исследовательский центр нейрохирургии имени академика Н.Н. Бурденко»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Semenov Institute of Chemical Physics</institution></aff><aff><institution xml:lang="ru">ФГБУН «Федеральный исследовательский центр химической физики имени Н.Н. Семенова»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2022</year></pub-date><volume>16</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>46</fpage><lpage>52</lpage><history><date date-type="received" iso-8601-date="2021-06-23"><day>23</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Asriyants S.V., Tomskiy A.A., Gamaleya A.A., Poddubskaya A.A., Sedov A.S., Pronin I.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Асриянц С.В., Томский А.А., Гамалея А.А., Поддубская А.А., Седов А.С., Пронин И.Н.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Asriyants S.V., Tomskiy A.A., Gamaleya A.A., Poddubskaya A.A., Sedov A.S., Pronin I.N.</copyright-holder><copyright-holder xml:lang="ru">Асриянц С.В., Томский А.А., Гамалея А.А., Поддубская А.А., Седов А.С., Пронин И.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/752">https://annaly-nevrologii.com/pathID/article/view/752</self-uri><abstract xml:lang="en"><p><bold>Introduction.</bold> Bilateral stimulation of the subthalamic nucleus (STN) is successfully used to treat advanced stages of Parkinson's disease. The standard surgical technique includes microelectrode recording and intraoperative stimulation. The introduction of 3T MRI into clinical practice and new impulse sequences have led to the question of whether the surgery can be performed under general anaesthesia.</p> <p><bold>Aim</bold> of the study: to compare the efficacy and safety of bilateral stimulation of STN in patients with Parkinson's disease, using 3T MRI under local and general anaesthesia.</p> <p><bold>Materials and methods. </bold>This prospective, randomized controlled study included 40 patients, who underwent electrode implantation using 3T MRI. The patients in the main group (n = 20) had electrodes implanted under general anaesthesia, while the control group (n = 20) had local anaesthesia, intraoperative stimulation and microelectrode recording. The patients’ motor status, quality of life, cognitive function and required levodopa dose were evaluated after 6 months.</p> <p><bold>Results.</bold> The results of 6 months of stimulation were obtained from 30 patients (15 from the main group and 15 from the control group). Reduced motor impairment was observed in both groups as measured on the UPDRS III scale during the 'off' time, with a reduction of 68.7% in the main group and 74.7% in the control group. Improved quality of life, reduced drug-induced motor complications and a reduction in the levodopa dose were also comparable in both groups. No intraoperative haemorrhagic complications were recorded during the study.</p> <p><bold>Conclusions.</bold> Preliminary analysis of the data showed that with high-quality visualization of the STN, electrode implantation under anaesthesia is equally effective to awake surgery.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение.</bold> Двусторонняя стимуляция субталамического ядра (СТЯ) успешно применяется для лечения развёрнутых стадий болезни Паркинсона. Стандартная техника выполнения операции включает проведение микроэлектродной регистрации и интраоперационной стимуляции. Внедрение в клиническую практику 3 Т МРТ и появление новых импульсных последовательностей ставят вопрос о возможности проведения операции в условиях общей анестезии.</p> <p><bold>Цель</bold> исследования: сравнить эффективность и безопасность двусторонней стимуляции СТЯ при болезни Паркинсона с применением 3 Т МРТ у пациентов, оперированных в условиях местной и общей анестезии.</p> <p><bold>Материалы и методы.</bold> В проспективное рандомизированное контролируемое исследование были включены 40 пациентов, которым проводили имплантацию электродов с применением 3 Т МРТ. Пациентам основной группы (n = 20) электроды имплантировали в условиях общей анестезии, пациентам контрольной группы (n = 20) — в условиях местной анестезии, интраоперационной стимуляции и микроэлектродной регистрации. Через 6 мес оценивали двигательный статус пациентов, качество жизни, когнитивные функции, необходимую дозу леводопы.</p> <p><bold>Результаты. </bold>Результаты 6-месячной стимуляции были собраны у 30 пациентов (15 из основной и 15 из контрольной группы). Уменьшение тяжести двигательных проявлений наблюдалось в обеих группах и по шкале UPDRS III в off-медикаментозном состоянии составило 68,7% в основной группе и 74,7% — в контрольной. Улучшение качества жизни, снижение тяжести двигательных осложнений медикаментозной терапии и уменьшение дозы леводопы также были сопоставимы в обеих группах. За время исследования не было зафиксировано ни одного интраоперационного геморрагического осложнения.</p> <p><bold>Выводы. </bold>Предварительный анализ данных показывает, что в условиях качественной визуализации СТЯ имплантация электродов в наркозе не уступает в эффективности операции в сознании.</p></trans-abstract><kwd-group xml:lang="en"><kwd>deep brain stimulation</kwd><kwd>Parkinson's disease</kwd><kwd>subthalamic nucleus</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>стимуляция глубоких структур мозга</kwd><kwd>болезнь Паркинсона</kwd><kwd>субталамическое ядро</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Weaver F., Follett K., Hur K. et al. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J Neurosurg. 2005;103(6):956–967. DOI: 10.3171/jns.2005.103.6.0956. PMID: 16381181.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Mansouri A., Taslimi S., Badhiwala J.H. et al. Deep brain stimulation for Parkinson’s disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg. 2018;128(4):1199–1213. DOI: 10.3171/2016.11.JNS16715. PMID: 28665252.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kerl H.U., Gerigk L., Pechlivanis I. et al. The subthalamic nucleus at 3.0 Tesla: choice of optimal sequence and orientation for deep brain stimulation using a standard installation protocol: clinical article. J Neurosurg. 2012;117(6):1155–1165. DOI: 10.3171/2012.8.JNS111930. PMID: 23039154.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cheng C.H., Huang H.M., Lin H.L., Chiou S.M. 1.5T versus 3T MRI for targeting subthalamic nucleus for deep brain stimulation. Br J Neurosurg. 2014;28(4):467–470. DOI: 10.3109/02688697.2013.854312. PMID: 24191703.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Longhi M., Ricciardi G., Tommasi G. et al. The role of 3T magnetic resonance imaging for targeting the human subthalamic nucleus in deep brain stimulation for Parkinson disease. J Neurol Surg A Cent Eur Neurosurg. 2015;76(3):181–189. DOI: 10.1055/s-0033-1354749. PMID: 25764475.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Chandran A.S., Bynevelt M., Lind C.R. Magnetic resonance imaging of the subthalamic nucleus for deep brain stimulation. J Neurosurg. 2016;124(1):96–105. DOI: 10.3171/2015.1.JNS142066. PMID: 26295914.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ho A.L., Ali R., Connolly I.D. et al. Awake versus asleep deep brain stimulation for Parkinson’s disease: a critical comparison and meta-analysis. J Neurol Neurosurg Psychiatry. 2018;89(7):687–691. DOI: 10.1136/jnnp-2016-314500. PMID: 28250028.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Chen T., Mirzadeh Z., Chapple K.M. et al. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2018;130(1):109–120. DOI: 10.3171/2017.8.JNS17883. PMID: 29547091.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Engelhardt J., Caire F., Damon-Perrière N. et al. A phase 2 randomized trial of asleep versus awake subthalamic nucleus deep brain stimulation for Parkinson’s disease. Stereotact Funct Neurosurg. 2021;99(3):230–240. DOI: 10.1159/000511424. PMID: 33254172.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Tsai S.T., Chen T.Y., Lin S.H., Chen S.Y. Five-year clinical outcomes of local versus general anesthesia deep brain stimulation for Parkinson’s disease. Parkinsons Dis. 2019;2019:5676345. DOI: 10.1155/2019/5676345. PMID: 30800263. [Erratum in Parkinsons Dis. 2019;2019:2654204. PMID: 31827761].</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Sheshadri V., Rowland N.C., Mehta J. et al. Comparison of general and local anesthesia for deep brain stimulator insertion: a systematic review. Can J Neurol Sci. 2017;44(6):697–704. DOI: 10.1017/cjn.2017.224. PMID: 28920562.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Yin Z., Luo Y., Jin Y. et al. Is awake physiological confirmation necessary for DBS treatment of Parkinson’s disease today? A comparison of intraoperative imaging, physiology, and physiology imaging-guided DBS in the past decade. Brain Stimul. 2019;12(4):893–900. DOI: 10.1016/j.brs.2019.03.006. PMID: 30876883.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Liu Z., He S., Li L. General anesthesia versus local anesthesia for deep brain stimulation in Parkinson’s disease: a meta-analysis. Stereotact Funct Neurosurg. 2019;97(5–6):381–390. DOI: 10.1159/000505079. PMID: 31962310.</mixed-citation></ref></ref-list></back></article>
